Coronary Disease/Myocardial Infarction
RSSArticles
-
Pharmacology Watch: Zolpidem and Risk of Falls in Hospitalized Patients
Zolpidem and risk of falls; AVR and anticoagulation; statins in cancer patients; and FDA actions. -
Preventing Inappropriate ICD Shocks
This study, the Multicenter Automatic Defibrillator Implantation Trial Reduce Inappropriate Therapy (MADIT-RIT), was designed to test the hypothesis that programming implantable cardioverter-defibrillator (ICD) therapies with higher detection rates or delayed detection before initiation of therapy would decrease inappropriate shocks in ICD patients. -
Embolic Risk in Endocarditis
-
Are Eligible Patients in the Community Receiving ICDs?
-
Esmolol in Septic Shock
-
Is There a Benefit to Cardiac Resynchronization Therapy in Patients with a Narrow QRS and Echocardiographic Dyssychrony?
-
Colchicine in Acute Pericarditis
-
Aortic Valve Replacement in Older Adults: Mechanical or Bioprosthetic Valve?
The decision to choose a mechanical or a tissue valve for patients undergoing surgical aortic valve replacement (AVR) is a complex one that involves synthesizing clinical factors such as risk of bleeding, likelihood of reoperation, and patient preference. Increasingly, older patients with more comorbidities are being referred for AVR surgery. -
PCI in Patients on Warfarin: Do We Need Dual Antiplatelet Therapy?
Many patients need to take long-term oral anticoagulants (OAC) for indications such as atrial fibrillation (AF) or mechanical prosthetic valves. -
Outcome of Mitral Valve Repair for Severe Mitral Regurgitation
Guideline-driven earlier mitral valve repair for patients with mitral regurgitation (MR) due to degenerative disease has increased in the last 25 years.